To include your compound in the COVID-19 Resource Center, submit it here.

CTLA4-Ig: Began Phase II testing

Repligen Corp. (RGEN), Needham, Mass.
Product: CTLA4-Ig
Business:

Read the full 87 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE